secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTEGRA LIFESCIENCES HOLDINGS CORP (IART)
CIK:        0000917520
Form:       8-K
Filed at:   2023-01-25T23:59:59+00:00
Accession:  0000917520-23-000008
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02
LLM model:  deepseek-v4-flash:cloud@v2

Integra LifeSciences raises adj EPS guidance for Q4 and FY2022 above prior expectations
--------------------------------------------------------------------------------

- Q4 2022 adjusted EPS expected $0.92-$0.96 vs $0.84 in Q4 2021; above Oct guidance high end.
- FY 2022 adjusted EPS expected $3.34-$3.38 vs $3.18 in FY 2021; above Oct guidance high end.
- Preliminary, unaudited results; full Q4 & FY 2022 earnings due Feb 22, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/917520/000091752023000008/0000917520-23-000008-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/917520/000091752023000008/iart-20230125.htm
  HTML page:      https://secwatch.observer/filing/0000917520-23-000008

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer